Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Qi and Yin deficiency is a pathological syndrome (Zheng) within Traditional Chinese Medicine (TCM) characterized by the concurrent depletion of vital energy (Qi) and body fluids or essence (Yin). It is not a singular molecular target, such as a receptor or enzyme, but rather a holistic clinical classification used to describe a state of multi-system physiological imbalance often observed in chronic illnesses (Wang et al., 2014, Evidence-Based Complementary and Alternative Medicine). Clinically, it manifests as fatigue, spontaneous sweating, dry mouth, and a weak, rapid pulse, frequently associated with conditions like Type 2 diabetes and chronic heart failure (Zhu et al., 2019, Journal of Diabetes Research). Modern pharmacological research suggests that this syndrome correlates with dysregulation in energy metabolism, oxidative stress, and immune dysfunction. Therapeutic strategies focus on 'tonifying' and 'nourishing' through polyherbal formulas like Shengmai San, which have been shown to influence mitochondrial efficiency and inflammatory pathways (Liu et al., 2018, Frontiers in Pharmacology). Because it represents a systemic state rather than a specific protein, it is considered an 'incorrect' entry if searched for as a conventional drug target, though it remains a significant focus for integrative medicine and systems biology research.
In Traditional Chinese Medicine, the mechanism is to tonify Qi (restore energy/function) and nourish Yin (replenish fluids/substance). Molecularly, treatments for this syndrome often modulate mitochondrial function, reduce oxidative stress, and regulate the hypothalamic-pituitary-adrenal (HPA) axis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Qi and Yin deficiency (QYD).